Sign in

CIK 0000318154

  • Large accelerated filer
Ticker
AMGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
953540776
Phone
+1 805-447-1000
Business address
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
  1. 4 Shares withheld for taxes SVP & CCO gave up 703 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP & CFO gave up 5,168 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP & Gen. Counsel & Secy. gave up 5,879 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP, Global Commercial Ops gave up 6,461 shares (to pay taxes)
  5. 4 Shares withheld for taxes VP, Finance & CAO gave up 146 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chairman, CEO and President gave up 20,560 shares (to pay taxes)
  7. 4 Grant or award EVP, Operations acquired 12,278 shares (grant or award)
  8. 4 Grant or award EVP & Chief Technology Officer acquired 12,407 shares (grant or award)
  9. 4 Grant or award SVP, Human Resources acquired 1,311 shares (grant or award)
  10. 4 Grant or award SVP, Business Development acquired 1,256 shares (grant or award)
  11. 4 Grant or award SVP & CCO acquired 1,954 shares (grant or award)
  12. 4 Grant or award EVP & CFO acquired 10,338 shares (grant or award)
  13. 4 Grant or award EVP & Gen. Counsel & Secy. acquired 11,760 shares (grant or award)
  14. 4 Grant or award EVP, Global Commercial Ops acquired 12,924 shares (grant or award)
  15. 4 Grant or award VP, Finance & CAO acquired 418 shares (grant or award)
  16. 4 Grant or award Chairman, CEO and President acquired 41,133 shares (grant or award)
  17. 4 Grant or award EVP, R&D, & Chief Sci. Officer acquired 22,393 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale SVP & CCO sold 2,096 shares at $273.03 ($572,276)
  20. 4 Gift EVP, Research and Development gave 165 shares (gift)

Page 13 of 99 · 1,961 filings